Does TAZEMETOSTAT Cause Malignant pleural effusion? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Malignant pleural effusion have been filed in association with TAZEMETOSTAT. This represents 11.0% of all adverse event reports for TAZEMETOSTAT.
11
Reports of Malignant pleural effusion with TAZEMETOSTAT
11.0%
of all TAZEMETOSTAT reports
0
Deaths
1
Hospitalizations
How Dangerous Is Malignant pleural effusion From TAZEMETOSTAT?
Of the 11 reports, 1 (9.1%) required hospitalization.
Is Malignant pleural effusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAZEMETOSTAT. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does TAZEMETOSTAT Cause?
Disease progression (26)
Neutropenia (12)
Blood lactate dehydrogenase increased (10)
Drug ineffective (10)
Lymphadenopathy (10)
Off label use (10)
Myelodysplastic syndrome (8)
Thrombocytopenia (8)
Anaemia (7)
Fatigue (6)
What Other Drugs Cause Malignant pleural effusion?
PEMBROLIZUMAB (97)
CARBOPLATIN (65)
BEVACIZUMAB (64)
LETROZOLE (63)
NIVOLUMAB (61)
FULVESTRANT (58)
PACLITAXEL (58)
PALBOCICLIB (55)
CYCLOPHOSPHAMIDE (49)
OSIMERTINIB (46)
Which TAZEMETOSTAT Alternatives Have Lower Malignant pleural effusion Risk?
TAZEMETOSTAT vs TAZEMETOSTAT HYDROBROMIDE
TAZEMETOSTAT vs TAZOBACTAM
TAZEMETOSTAT vs TBO-FILGRASTIM
TAZEMETOSTAT vs TEBENTAFUSP-TEBN
TAZEMETOSTAT vs TECFIDERA